Citizens Reiterates Buy Rating for AMN Healthcare
Citizens has reaffirmed its buy rating on AMN Healthcare with a new price target, a 17.07% upside from the current price.
Key Points
- Citizens reiterated its buy rating for AMN Healthcare Services, Inc. (NYSE:AMN) with a $36 price target on June 23, 2026.
- Citizens's $36 price target implies 17.07% upside from AMN Healthcare Services, Inc.'s ($AMN) current $30.75 share price.
- Shares of AMN traded at approximately $31.11 on Tuesday, with a market cap of $1.18 billion and a forward P/E ratio of 27.94.
- Recent insider activity includes planned sales by Mark Foletta and purchases by Sylvia Trent-Adams and Jorge Caballero.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 23, 2026, Citizens reiterated its buy rating for AMN Healthcare Services, Inc. (NYSE:AMN), setting a price target of $36. This update comes as the stock traded around $31.11 on Tuesday.
Analysts Set New Price Targets
On June 23, 2026, Citizens reiterated its buy rating for AMN Healthcare Services with a price target of $36. UBS maintained its hold rating with a $32 target on May 13, 2026, while BMO Capital and Baird both maintained buy and hold ratings respectively, each with a $26 target on May 11, 2026.
AMN Healthcare Services, Inc. Stock Down 11.2%
Shares of NYSE:AMN traded near $31.11 on Tuesday. AMN Healthcare Services, Inc. has a market cap of about $1.18 billion and a forward P/E ratio of 27.94. The stock's 52-week range is between $14.87 and $33.13, with a 50-day moving average of $25.66 and a 200-day moving average of $20.31. The company has a current ratio of 1.088 and a quick ratio of 0.96, with a debt-to-equity ratio of 108.99.
$AMN price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Insider Buying and Selling at AMN Healthcare Services, Inc.
Recent insider transactions include Mark Foletta selling 3,681 shares at an average price of $31.07 on June 15, 2026, under a planned sale. Sylvia Trent-Adams purchased 8,304 shares on May 1, 2026, without a disclosed price, and Jorge Caballero also bought 8,325 shares on the same date.
About AMN Healthcare Services, Inc.
AMN Healthcare Services, Inc., headquartered in Dallas, Texas, provides technology-enabled healthcare workforce solutions and staffing services across the United States. The company operates through segments such as Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. Under the leadership of CEO Ms. Caroline Sullivan Grace, AMN Healthcare offers a variety of staffing services including travel nurse staffing and allied health professionals. The company was founded in 1985 and employs approximately 2,664 people.
Bottom Line
Citizens' reaffirmation of its buy rating for AMN Healthcare Services, with a $36 target, highlights ongoing interest in the company's stock. Investors often track these analyst ratings to gauge market sentiment. It’s important to remember that such ratings are based on past performance and projections, which may not reflect current market conditions.
Get AMN Healthcare Services, Inc. alerts
New 13F filings, insider trades, and analyst moves on $AMN, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.